247 related articles for article (PubMed ID: 3771767)
1. Comparison of 15 laboratory and patient-derived strains of Mycobacterium avium for ability to infect and multiply in cultured human macrophages.
Crowle AJ; Tsang AY; Vatter AE; May MH
J Clin Microbiol; 1986 Nov; 24(5):812-21. PubMed ID: 3771767
[TBL] [Abstract][Full Text] [Related]
2. Pathogenicity of Mycobacterium avium for human monocytes: absence of macrophage-activating factor activity of gamma interferon.
Toba H; Crawford JT; Ellner JJ
Infect Immun; 1989 Jan; 57(1):239-44. PubMed ID: 2491838
[TBL] [Abstract][Full Text] [Related]
3. Characterization and growth in human macrophages of Mycobacterium avium complex strains isolated from the blood of patients with acquired immunodeficiency syndrome.
Meylan PR; Richman DD; Kornbluth RS
Infect Immun; 1990 Aug; 58(8):2564-8. PubMed ID: 2370109
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the abilities of Mycobacterium avium and Mycobacterium intracellulare to infect and multiply in cultured human macrophages from normal and human immunodeficiency virus-infected subjects.
Crowle AJ; Ross ER; Cohn DL; Gilden J; May MH
Infect Immun; 1992 Sep; 60(9):3697-703. PubMed ID: 1500179
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by normal human serum of Mycobacterium avium multiplication in cultured human macrophages.
Crowle AJ; Poche P
Infect Immun; 1989 Apr; 57(4):1332-5. PubMed ID: 2494117
[TBL] [Abstract][Full Text] [Related]
6. Control of mycobacterial replication in human macrophages: roles of extracellular signal-regulated kinases 1 and 2 and p38 mitogen-activated protein kinase pathways.
Blumenthal A; Ehlers S; Ernst M; Flad HD; Reiling N
Infect Immun; 2002 Sep; 70(9):4961-7. PubMed ID: 12183542
[TBL] [Abstract][Full Text] [Related]
7. Evidence that vesicles containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidic.
Crowle AJ; Dahl R; Ross E; May MH
Infect Immun; 1991 May; 59(5):1823-31. PubMed ID: 1902198
[TBL] [Abstract][Full Text] [Related]
8. Virulence of
Rindi L; Lari N; Garzelli C
Int J Mycobacteriol; 2018; 7(1):48-52. PubMed ID: 29516886
[TBL] [Abstract][Full Text] [Related]
9. Effects on Mycobacterium avium replication in normal human macrophages by deferiprone (L1) and other iron chelators. Possible implications on toxicity.
Douvas GS; May MH; Kolnagou A; Kontoghiorghes GJ
Arzneimittelforschung; 2002; 52(1):45-52. PubMed ID: 11838274
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium, and rifampin against M. tuberculosis in cultured human macrophages.
Crowle AJ; Elkins N; May MH
Am Rev Respir Dis; 1988 May; 137(5):1141-6. PubMed ID: 3143278
[TBL] [Abstract][Full Text] [Related]
11. Temporal effect of tumor necrosis factor alpha on murine macrophages infected with Mycobacterium avium.
Eriks IS; Emerson CL
Infect Immun; 1997 Jun; 65(6):2100-6. PubMed ID: 9169738
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the virulence of Mycobacterium avium complex (MAC) isolates in mice.
Pedrosa J; Flórido M; Kunze ZM; Castro AG; Portaels F; McFadden J; Silva MT; Appelberg R
Clin Exp Immunol; 1994 Nov; 98(2):210-6. PubMed ID: 7955524
[TBL] [Abstract][Full Text] [Related]
13. Characterization of inhibition of Mycobacterium avium replication in macrophages by normal human serum.
Douvas GS; May MH; Ross E; Crowle AJ
Infect Immun; 1992 Feb; 60(2):345-52. PubMed ID: 1730466
[TBL] [Abstract][Full Text] [Related]
14. Evidence that host-recycling of Mycobacterium avium preserves its ability to hinder macrophage killing functions.
Fréhel C; Thorel MF; Rastogi N
Acta Leprol; 1989; 7 Suppl 1():160-3. PubMed ID: 2503977
[TBL] [Abstract][Full Text] [Related]
15. Killing of Mycobacterium avium subspecies paratuberculosis within macrophages.
Bannantine JP; Stabel JR
BMC Microbiol; 2002; 2():2. PubMed ID: 11860602
[TBL] [Abstract][Full Text] [Related]
16. Recombinant tumour necrosis factor-alpha decreases whereas recombinant interleukin-6 increases growth of a virulent strain of Mycobacterium avium in human macrophages.
Denis M; Gregg EO
Immunology; 1990 Sep; 71(1):139-41. PubMed ID: 2120128
[TBL] [Abstract][Full Text] [Related]
17. Strain- and donor-related differences in the interaction of Mycobacterium avium with human monocytes and its modulation by interferon-gamma.
Shiratsuchi H; Johnson JL; Toba H; Ellner JJ
J Infect Dis; 1990 Oct; 162(4):932-8. PubMed ID: 2152242
[TBL] [Abstract][Full Text] [Related]
18. The phagosomal environment protects virulent Mycobacterium avium from killing and destruction by clarithromycin.
Fréhel C; Offredo C; de Chastellier C
Infect Immun; 1997 Jul; 65(7):2792-802. PubMed ID: 9199452
[TBL] [Abstract][Full Text] [Related]
19. Relationship between virulence of Mycobacterium avium strains and induction of tumor necrosis factor alpha production in infected mice and in in vitro-cultured mouse macrophages.
Sarmento AM; Appelberg R
Infect Immun; 1995 Oct; 63(10):3759-64. PubMed ID: 7558277
[TBL] [Abstract][Full Text] [Related]
20. Cytokine stimulation of parasitic and microbial growth.
Denis M; Campbell D; Gregg EO
Res Microbiol; 1991; 142(9):979-83. PubMed ID: 1805312
[No Abstract] [Full Text] [Related]
[Next] [New Search]
